Are central nervous system drugs displaying anti-inflammatory activity suitable for early treatment of COVID-19?

نویسندگان

چکیده

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Grieb P, Rejdak K. Are central nervous system drugs displaying anti-inflammatory activity suitable for early treatment of COVID-19?. Folia Neuropathologica. 2021;59(2):113-120. doi:10.5114/fn.2021.107572. APA Grieb, P., & Rejdak, (2021). Neuropathologica, 59(2), 113-120. https://doi.org/10.5114/fn.2021.107572 Chicago Paweł, and Konrad Rejdak. 2021. "Are COVID-19?". Neuropathologica 59 (2): Harvard pp.113-120. MLA Paweł et al. COVID-19?." vol. 59, no. 2, 2021, pp. Vancouver

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Review of Anti-inflammatory and Immunosuppressive Drugs Used in COVID-19 Epidemic

Introduction: Immunosuppressive drugs are classified into different groups depending on the mechanism of action and are used in the control of acute and chronic inflammatory disorders. Considering the possibility of severe inflammatory complications such as acute respiratory failure and cytokine storm in the patients with COVID-19, there is a need to review the updated data on the effectiveness...

متن کامل

Anti-Inflammatory Activity of a Selection of Antidepressant Drugs

      Anti-inflammatory activity has been reported for a few of antidepressant drugs and in contrary sertraline has potentiated inflammation. In this study, anti-inflammatory effect of a collection of antidepressant drugs belonging to different classes was evaluated to help a rational selection of these drugs in disease conditions such as association of depression or anxiety with inflammatory d...

متن کامل

COVID-19: combining antiviral and anti-inflammatory treatments

The high affinity of baricitinib for the numb-associated kinase (NAK) family, its anti-inflammatory properties, with its advantageous pharmacokinetic properties, appear to make it a special case among the approved drugs.  In addition, the potential for combination therapy with baracitinib is high, because of its low plasma protein binding and minimal interaction with CYP enzymes and drug transp...

متن کامل

Novel Tuberculostatic Agents Suitable for Treatment of Mycobacterium tuberculosis Infections of the Central Nervous System

Aims: To demonstrate the efficacy of five small molecule compounds for inhibiting the growth of Mycobacterium tuberculosis. To present evidence that these compounds will penetrate into the central nervous system. Study Design: Five small molecule compounds bearing a hydrazide group were synthesized utilizing microwave excitation. These compounds were then placed into tissue culture with Mycobac...

متن کامل

Drugs in Central Nervous System Disorders

This book is the second in a series entitled "Clinical Pharmacology," edited by Murray Weiner. The volume contains six chapters, of varying quality, by authors who have been researchers in the area of neuropharmacology. The first chapter, "Centrally Acting Analgesics," is a well-documented (517 references), timely, and complete review of the newest research in the pharmacology and physiology of...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Folia Neuropathologica

سال: 2021

ISSN: ['1641-4640', '1509-572X']

DOI: https://doi.org/10.5114/fn.2021.107572